NRAS c.541_542delinsGC ;(p.C181A)

Variant ID: 1-115251184-CA-GC

NM_002524.4(NRAS):c.541_542delinsGC;(p.C181A)

This variant was identified in 11 publications

View GRCh38 version.




Publications:


A review of the biological and clinical implications of RAS-MAPK pathway alterations in neuroblastoma.

Journal Of Experimental & Clinical Cancer Research : Cr
Mlakar, Vid V; Morel, Edouard E; Mlakar, Simona Jurkovic SJ; Ansari, Marc M; Gumy-Pause, Fabienne F
Publication Date: 2021-06-08

Variant appearance in text: NRAS: C181A
PubMed Link: 34103089
Variant Present in the following documents:
  • Main text
  • 13046_2021_Article_1967.pdf
View BVdb publication page



Does the gene matter? Genotype-phenotype and genotype-outcome associations in congenital melanocytic naevi.

The British Journal Of Dermatology
Polubothu, S S; McGuire, N N; Al-Olabi, L L; Baird, W W; Bulstrode, N N; Chalker, J J; Josifova, D D; Lomas, D D; O'Hara, J J; Ong, J J; Rampling, D D; Stadnik, P P; Thomas, A A; Wedgeworth, E E; Sebire, N J NJ; Kinsler, V A VA
Publication Date: 2020-02

Variant appearance in text: NRAS: C181A
PubMed Link: 31111470
Variant Present in the following documents:
  • Main text
  • BJD-182-434.pdf
View BVdb publication page



Functional annotation of rare gene aberration drivers of pancreatic cancer.

Nature Communications
Tsang, Yiu Huen YH; Dogruluk, Turgut T; Tedeschi, Philip M PM; Wardwell-Ozgo, Joanna J; Lu, Hengyu H; Espitia, Maribel M; Nair, Nikitha N; Minelli, Rosalba R; Chong, Zechen Z; Chen, Fengju F; Chang, Qing Edward QE; Dennison, Jennifer B JB; Dogruluk, Armel A; Li, Min M; Ying, Haoqiang H; Bertino, Joseph R JR; Gingras, Marie-Claude MC; Ittmann, Michael M; Kerrigan, John J; Chen, Ken K; Creighton, Chad J CJ; Eterovic, Karina K; Mills, Gordon B GB; Scott, Kenneth L KL
Publication Date: 2016-01-25

Variant appearance in text: NRAS: C181A
PubMed Link: 26806015
Variant Present in the following documents:
  • ncomms10500-s2.xls, sheet 1
View BVdb publication page



Phase II Pilot Study of Vemurafenib in Patients With Metastatic BRAF-Mutated Colorectal Cancer.

Journal Of Clinical Oncology : Official Journal Of The American Society Of Clinical Oncology
Kopetz, Scott S; Desai, Jayesh J; Chan, Emily E; Hecht, Joel Randolph JR; O'Dwyer, Peter J PJ; Maru, Dipen D; Morris, Van V; Janku, Filip F; Dasari, Arvind A; Chung, Woonbook W; Issa, Jean-Pierre J JP; Gibbs, Peter P; James, Brian B; Powis, Garth G; Nolop, Keith B KB; Bhattacharya, Suman S; Saltz, Leonard L
Publication Date: 2015-12-01

Variant appearance in text: NRAS: c181a
PubMed Link: 26460303
Variant Present in the following documents:
  • supp_33.34.4032_DS_2015.632497.pdf
View BVdb publication page



Protein kinase Cδ is a therapeutic target in malignant melanoma with NRAS mutation.

Acs Chemical Biology
Takashima, Asami A; English, Brandon B; Chen, Zhihong Z; Cao, Juxiang J; Cui, Rutao R; Williams, Robert M RM; Faller, Douglas V DV
Publication Date: 2014-04-18

Variant appearance in text: NRAS: C181A
PubMed Link: 24506253
Variant Present in the following documents:
  • Main text
View BVdb publication page



Low BRAF and NRAS expression levels are associated with clinical benefit from DTIC therapy and prognosis in metastatic melanoma.

Clinical & Experimental Metastasis
Birkeland, Einar E; Busch, Christian C; Berge, Elisabet Ognedal EO; Geisler, Jürgen J; Jönsson, Göran G; Lillehaug, Johan Richard JR; Knappskog, Stian S; Lønning, Per Eystein PE
Publication Date: 2013-10

Variant appearance in text: NRAS: C181A
PubMed Link: 23673558
Variant Present in the following documents:
  • 10585_2013_9587_MOESM1_ESM.pdf
View BVdb publication page



Abrogation of BRAFV600E-induced senescence by PI3K pathway activation contributes to melanomagenesis.

Genes & Development
Vredeveld, Liesbeth C W LC; Possik, Patricia A PA; Smit, Marjon A MA; Meissl, Katrin K; Michaloglou, Chrysiis C; Horlings, Hugo M HM; Ajouaou, Abderrahim A; Kortman, Pim C PC; Dankort, David D; McMahon, Martin M; Mooi, Wolter J WJ; Peeper, Daniel S DS
Publication Date: 2012-05-15

Variant appearance in text: NRAS: C181A
PubMed Link: 22549727
Variant Present in the following documents:
  • Main text
View BVdb publication page



Phase II, open-label, randomized trial of the MEK1/2 inhibitor selumetinib as monotherapy versus temozolomide in patients with advanced melanoma.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Kirkwood, John M JM; Bastholt, Lars L; Robert, Caroline C; Sosman, Jeff J; Larkin, James J; Hersey, Peter P; Middleton, Mark M; Cantarini, Mireille M; Zazulina, Victoria V; Kemsley, Karin K; Dummer, Reinhard R
Publication Date: 2012-01-15

Variant appearance in text: NRAS: C181A
PubMed Link: 22048237
Variant Present in the following documents:
  • Main text
View BVdb publication page



Clinical correlates of NRAS and BRAF mutations in primary human melanoma.

Clinical Cancer Research : An Official Journal Of The American Association For Cancer Research
Ellerhorst, Julie A JA; Greene, Victoria R VR; Ekmekcioglu, Suhendan S; Warneke, Carla L CL; Johnson, Marcella M MM; Cooke, Carolyn P CP; Wang, Li-E LE; Prieto, Victor G VG; Gershenwald, Jeffrey E JE; Wei, Qingyi Q; Grimm, Elizabeth A EA
Publication Date: 2011-01-15

Variant appearance in text: NRAS: C181A
PubMed Link: 20975100
Variant Present in the following documents:
  • Main text
View BVdb publication page



Frequencies of NRAS and BRAF mutations increase from the radial to the vertical growth phase in cutaneous melanoma.

The Journal Of Investigative Dermatology
Greene, Victoria R VR; Johnson, Marcella M MM; Grimm, Elizabeth A EA; Ellerhorst, Julie A JA
Publication Date: 2009-06

Variant appearance in text: NRAS: C181A
PubMed Link: 19037234
Variant Present in the following documents:
  • Main text
View BVdb publication page



BRAF and NRAS mutations are uncommon in melanomas arising in diverse internal organs.

Journal Of Clinical Pathology
Wong, C W CW; Fan, Y S YS; Chan, T L TL; Chan, A S W AS; Ho, L C LC; Ma, T K F TK; Yuen, S T ST; Leung, S Y SY; ,
Publication Date: 2005-06

Variant appearance in text: NRAS: C181A
PubMed Link: 15917418
Variant Present in the following documents:
  • Main text
View BVdb publication page